SCFAs also act on HDACs by inhibiting the action of monocytes and neutrophils, reducing TNF production and leading to inactivation of transcription factor-nuclear factor-κB (NF-κB) [107], attenuating the inflammatory response in CKD patients. The gene discussed is TNF; the disease is chronic kidney disease.